P53-protein accumulation and MDM2-protein overexpression in gastric carcinomas. No apparent correlation with survival

Pathology Research and Practice

Volumn 195, Issue 12, 1999, Pages 815-820

  Kasper, Hans Udo ^a   Schneider Stock, Regine ^a   Mellin, Walter ^a   Günther, Thomas ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Gastric cancer; Immunohistochemistry; MDM2; p53; Prognosis

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR LOCALIZATION;

EID: 0032784411     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(99)80103-4     Document Type: Article

References (34)

1. Ambos RA, Sheehan CE, Kallakury BV, Ross JS, et al. (1996) MDM2 and p53 accumulation in the histological subtypes of endometrial carcinoma. Mod Pathol 9: 1165-1169
2. Blok P, Craanen ME, Dekker W, Offerhaus GJA, Tytgat GNJ (1998) No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol 186: 36-40
3. Blok P, Craanen ME, Offerhaus GJA, Dekker W, et al. (1999) Molecular alterations in early gastric carcinomas. No apparent correlation with helicobacter pylori status. Am J Clin Pathol 111: 241-247
4. Freedman DA, Wu L, Levine AJ (1999) Functions of the MDM2 oncoprotein. Cell Mol Life Sci 55: 69-107
5. Gabbert HE, Müller W, Schneiders A, Meier S, Hommel G (1995) The relationship of p53 accumulation to the prognosis of 418 patients with gastric carcinoma. Cancer 76: 720-726
6. Haines DS (1997) The mdm2 proto-oncogene. Leuk Lymphoma 26: 227-238
7. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299
8. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53
9. Hong SI, Hong WS, Jang JJ, Lee DS, Cho NA, et al. (1994) Alterations of p53 gene in primary gastric cancer tissue. Anticancer Res 14: 1251-1256
10. Hong WS, Hong SI, Lee DS, Youngsook S (1994) Effect of non-tumor cell contamination on detection of p53 gene mutations in human gastric cancer cell lines by polymerase chain reaction single-strand conformation polymorphism analysis. Korean J Intern Med 9: 20-24
11. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, Caporaso NE, Fraumeni F, Rice JM (1995) Mutations of the k-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res 55. 2665-2672
12. Ichiyoshi Y, Oiwa H, Tomisaki S, Sakaguchi Y, et al. (1997) Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer. Hepatogastroenterology 44: 546-553
13. Jones SN, hancock AR, Vogel H, Donehower LA, Bradley A (1998) Overexpression of MDM2 in mice reveals a p53-independent role for MDM2 in tumorigenesis. Proc Natl Acad Sci US A 95: 15608-15612
14. Joypaul BV, Newman EL, Hopwood D, Grant A, Qureshi S, Lane DP, Cuschieri A (1993) Expression of p53 protein in normal, dysplastic and malignant gastric mucosa: An immunohistochemical study. J Pathol 170: 279-283
15. Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, Inoue H, Fukuma H (1994) Nuclear immunoreaction of p53 protein in soft tissue sarcomas. Cancer 73. 2499-2505
16. Kim JH, Choi JJ, Noh SH, Roh JK, Min JS, et al. (1993) Comparison of p53 gene mutation in paired primary and metastatic gastric tumor tissues. J Korean Med Science 8: 187-191
17. Kim JH, Uhm HD, Gong SJ, Shin DH, et al. (1997) Relationship between p53 accumulation and gastric cancer progression. Oncology 54: 166-170
18. Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by MDM2. Nature 387: 299-303
19. Lauren P (1965) The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-94
20. Meltzer PS (1994) MDM2 and p53: a question of balance. J Natl Cancer Inst 86: 1265-1266
21. Midgley CA, Lane DP (1997) p53 protein stability in tumor cells is not determined by mutation but is dependent on MDM2 binding. Oncogene 15: 1001-1010
22. Mietz JA, Unger T, Huibregtse JM, Howley PM (1992) The transcriptional transactivation function of wildtype-p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J 11: 5013-5020
23. Momand J, Jung D, Eilczynski S, Niland J (1998) The MDM2 gene amplification database. Nucleic Acids Research 26:3453-3459
24. Ochiai A, Yamauchi Y, Hirohashi S (1996) p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int J Cancer Pred Oncol 69: 28-33
25. Pedanna N, Holt S, Verma RS (1995) Genetics of gastric cancer. Anticancer Res 15: 2055-2064
26. Poremba C, Bankfalvi A, Dockhorn-Dworniczak B (1996) Das Tumorsuppressorgen p53. Pathologe 17: 181-188
27. Pruneri G, Pignataro L, Carboni N, Luminari S, et al. (1997) MDM2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild type p53 accumulation. Mod Pathol 10: 785-792
28. Renault B, Broek M van den, Fodde R, Wijnen J, Pellegata NS, et al. (1993) Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 53: 2614-2617
29. Sakurai S, Sano T, Nakajima T (1995) Clinicopathologic and molecular biological studies of gastric adenomas with special reference to p53 abnormalities. Pathol Intern 45: 51-57
30. Tang H, Hokita S, Che X, Baba M, et al. (1997) Comparison of p53 accumulation in proximal and distal gastric cancer: histopathologic correlation and prognostic significance. Ann Surg Oncol 4: 470-474
31. Thut CJ, Goodrich JA, Tijan R (1997) Repression of p53 mediated transcription by MDM2: a dual mechanism. Genes Dev 11: 1974-1986
32. Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70: 523-526
33. Vojtesek B, Bartek J, Midgley CA, Lane DP (1992) An immunochemical analysis of the human nuclear phosphoprotein p53: New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Meth 1523. 237-244
34. Yamada Y, Yoshida T, Hayashi K, Sekiya T, Yokota J, et al. (1991) p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res 51: 5800-5805